Chemours Co (CC) Reaches $37.98 After 6.00% Up Move; Robotti Robert Cut Omnova Solutions (OMN) Holding

June 19, 2017 - By Adrian Erickson

The stock of Chemours Co (NYSE:CC) is a huge mover today! About 1.78 million shares traded. Chemours Co (NYSE:CC) has risen 327.71% since June 19, 2016 and is uptrending. It has outperformed by 311.01% the S&P500.The move comes after 9 months positive chart setup for the $6.94B company. It was reported on Jun, 19 by Barchart.com. We have $40.26 PT which if reached, will make NYSE:CC worth $416.40M more.

Robotti Robert decreased Omnova Solutions Inc (OMN) stake by 3.45% reported in 2016Q4 SEC filing. Robotti Robert sold 36,825 shares as Omnova Solutions Inc (OMN)’s stock declined 3.85%. The Robotti Robert holds 1.03M shares with $10.31M value, down from 1.07 million last quarter. Omnova Solutions Inc now has $387.86 million valuation. The stock rose 0.34% or $0.03 reaching $8.78. About 26,692 shares traded. OMNOVA Solutions Inc. (NYSE:OMN) has risen 33.59% since June 19, 2016 and is uptrending. It has outperformed by 16.89% the S&P500.

Analysts await OMNOVA Solutions Inc. (NYSE:OMN) to report earnings on July, 5. They expect $0.16 EPS, down 11.11% or $0.02 from last year’s $0.18 per share. OMN’s profit will be $7.07 million for 13.72 P/E if the $0.16 EPS becomes a reality. After $0.05 actual EPS reported by OMNOVA Solutions Inc. for the previous quarter, Wall Street now forecasts 220.00% EPS growth.

Since April 5, 2017, it had 0 insider buys, and 1 insider sale for $320,065 activity. Shares for $320,065 were sold by LEMAY JAMES C on Wednesday, April 5.

Among 2 analysts covering Omnova Solutions (NYSE:OMN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Omnova Solutions had 2 analyst reports since September 28, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Friday, June 16 report. The rating was maintained by Deutsche Bank on Monday, September 28 with “Buy”.

Investors sentiment decreased to 0.72 in 2016 Q4. Its down 0.49, from 1.21 in 2016Q3. It turned negative, as 18 investors sold OMN shares while 47 reduced holdings. 10 funds opened positions while 37 raised stakes. 36.69 million shares or 0.74% less from 36.97 million shares in 2016Q3 were reported. Amp Limited invested 0% in OMNOVA Solutions Inc. (NYSE:OMN). Winslow Asset invested in 2.42% or 1.15 million shares. Tfs has 10,403 shares for 0.03% of their portfolio. State Board Of Administration Of Florida Retirement Sys has invested 0% of its portfolio in OMNOVA Solutions Inc. (NYSE:OMN). North Star Corp accumulated 2,000 shares or 0% of the stock. Blackrock Gru Ltd has invested 0% in OMNOVA Solutions Inc. (NYSE:OMN). Mckinley Cap Mgmt Llc Delaware stated it has 5,870 shares. Northern Trust has invested 0% in OMNOVA Solutions Inc. (NYSE:OMN). Voya Investment Mngmt Llc owns 24,810 shares. Morgan Stanley stated it has 161,202 shares. First Advsr Ltd Partnership holds 0% in OMNOVA Solutions Inc. (NYSE:OMN) or 47,562 shares. Prelude Mngmt Limited Liability Corporation holds 0.05% or 42,500 shares. Royal Comml Bank Of Canada stated it has 0.02% of its portfolio in OMNOVA Solutions Inc. (NYSE:OMN). Moreover, Citigroup Inc has 0% invested in OMNOVA Solutions Inc. (NYSE:OMN) for 53,428 shares. Teton Advsr stated it has 260,000 shares.

The Chemours Company is a provider of performance chemicals. The company has market cap of $6.94 billion. The Firm operates through three divisions: Titanium Technologies, Fluoroproducts and Chemical Solutions. It has a 70.01 P/E ratio. The Titanium Technologies segment is a producer of titanium dioxide .

Analysts await Chemours Co (NYSE:CC) to report earnings on August, 14. They expect $0.71 earnings per share, up 162.96% or $0.44 from last year’s $0.27 per share. CC’s profit will be $129.74 million for 13.37 P/E if the $0.71 EPS becomes a reality. After $0.75 actual earnings per share reported by Chemours Co for the previous quarter, Wall Street now forecasts -5.33% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: